![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 471/04 | (2006.01) |
A61K 31/519 | (2006.01) |
(11) | Number of the document | 2057156 |
(13) | Kind of document | T |
(96) | European patent application number | 07789277.6 |
Date of filing the European patent application | 2007-08-21 | |
(97) | Date of publication of the European application | 2009-05-13 |
(45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
(46) | Date of publication of the claims translation | 2017-05-25 |
(86) | Number | PCT/GB2007/003179 |
Date | 2007-08-21 |
(87) | Number | WO 2008/023161 |
Date | 2008-02-28 |
(30) | Number | Date | Country code |
823311 P | 2006-08-23 | US | |
938776 P | 2007-05-18 | US |
(72) |
DUGGAN, Heather Mary Ellen, GB
LEROUX, Frederic Georges Marie, GB
MALAGU, Karine, GB
MARTIN, Niall, Morrisson, Barr, GB
MENEAR, Keith, Allan, GB
SMITH, Graeme, Cameron, Murray, GB
|
(73) |
KuDOS Pharmaceuticals Limited,
1 Francis Crick Avenue, Cambridge Biomedical Campus Cambridge CB2 0AA,
GB
|
(74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
(54) | 2-Metilmorfolino pirido-, pirazo- ir pirimidopirimidino dariniai kaip mTOR slopikliai |
2-METHYLMORPHOLINE PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS |
Payment date | Validity (years) | Amount | |
2020-07-24 | 14 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2021-08-21 |